WOBURN, Mass., March 14, 2025 /PRNewswire/ — Azurity Pharmaceuticals (“Azurity”) announced today the successful completion of its acquisition of Covis Group S.Ã r.l. (“Covis”) from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This…